CHERYL LEMMON: Open Payments
NPI 1629091525 · PITTSBURG, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 35 payments from 7 companies in 2025. Trend: 2023 $154 · 2024 $665 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $302 |
| E.R. Squibb & Sons, L.L.C. | 5 | $273 |
| Teva Pharmaceuticals USA, Inc. | 5 | $270 |
| Alkermes, Inc. | 3 | $177 |
| Otsuka America Pharmaceutical, Inc. | 6 | $171 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, LYBALVI, Auvelity, REXULTI, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across KS — which companies pay providers there.
